Diagnosis: Generalized granuloma annulare
A 55-year-old male with a history of poorly controlled diabetes presented with widespread annular plaques on the trunk and extremities. The lesions were asymptomatic and had gradually increased in size over the past six months, raising concerns for a possible systemic condition.
The patient is a 55-year-old male with a six-month history of asymptomatic, widespread skin lesions. Upon examination, he presented with multiple annular, flesh-colored plaques measuring 1-3 cm in diameter, predominantly located on the trunk and extremities. The plaques exhibited a smooth surface, with no associated erythema or scaling.Distribution: Lesions are predominantly on the trunk and extremities.Number of lesions: Numerous, with some coalescing to form larger plaques.Surface characteristics: Smooth and flesh-colored, without scaling or ulceration.Symptomatology: Asymptomatic, with no pruritus or pain reported.Associated findings: No other dermatological or systemic findings on examination.
The patient reported that the lesions began insidiously approximately six months ago, with no identifiable triggers. He has a significant medical history of type 2 diabetes mellitus, which has been poorly controlled. The patient has not sought treatment for the skin lesions until now. His family history is unremarkable for autoimmune or skin diseases, and he denies any recent infections or medication use that could contribute to his skin condition.Onset: Insidious onset over six months.Triggers: No identifiable triggers noted.Prior treatments: None attempted for the skin lesions.Medical history: Type 2 diabetes mellitus, poorly controlled.Family history: No significant autoimmune or dermatological conditions.Social history: Non-smoker, no recent travel.
Acute / First-Line ManagementTopical corticosteroids (e.g., clobetasol propionate 0.05% ointment applied twice daily) for localized lesions.In cases of extensive involvement, triamcinolone acetonide 10-40 mg/mL can be injected intralesionally.Consideration of oral corticosteroids (e.g., prednisone 0.5-1 mg/kg/day for 1-2 weeks) in severe cases.Workup and Diagnostic ConfirmationClinical diagnosis is often sufficient; however, a skin biopsy can be performed to rule out other conditions. Histopathological examination typically shows a moderate dermal infiltrate of histiocytes.Consider laboratory tests to evaluate for underlying systemic conditions, especially in patients with risk factors like diabetes.Long-Term ManagementMonitor for spontaneous resolution, which may occur in many cases over months to years.For persistent cases, consider oral dapsone (50-100 mg daily) or methotrexate (15-25 mg weekly) as second-line therapies.Patient education on the benign nature of the condition and reassurance is essential.
Granuloma annulare: Characterized by annular plaques, often asymptomatic, and commonly seen in adults. Distinguishing features include flesh-colored lesions without scaling.Psoriasis: Typically presents with well-defined, erythematous plaques covered with silvery scales. Often pruritic and may have a family history.Discoid lupus erythematosus: Chronic condition with erythematous plaques and scaling, often with scarring. Affected areas may demonstrate central atrophy.Fungal infection: Tinea corporis may mimic annular lesions but usually presents with scaling and a raised border. KOH preparation can confirm the diagnosis.Subcutaneous sarcoidosis: Can present with annular lesions but typically involves deeper tissues and may have associated systemic symptoms.Other connective tissue diseases: Conditions like scleroderma or dermatomyositis may present with skin findings but usually have systemic involvement.Non-Hodgkin lymphoma: May present with cutaneous lesions; however, these typically show signs of malignancy and systemic symptoms.Secondary granulomatous dermatitis: Associated with infections, foreign bodies, or systemic diseases, requiring thorough evaluation.
High-Yield PearlsDiagnosis: Granuloma annulare is often a clinical diagnosis, with histopathology reserved for atypical cases.Management: Topical corticosteroids are the first-line treatment, while intralesional injections can be effective for larger lesions.Prognosis: The condition is generally self-limiting, with many cases resolving spontaneously over time.Association: Granuloma annulare may be associated with underlying systemic diseases, particularly diabetes mellitus.Awareness: Clinicians should be aware of the benign nature of granuloma annulare to avoid unnecessary interventions.Granuloma annulare is a self-limited condition often requiring reassurance rather than aggressive treatment.
Tags: granuloma annulare